FIELD: medicine.
SUBSTANCE: invention relates to the use of hexamethylenediamine bis-(-N-hexanoyl-L-seryl-L-lysine) as an analgesic, anxiolytic and antiaddictive agent.
EFFECT: hexamethylenediamine bis-(-N-hexanoyl-L-seryl-L-lysine) affects nociceptive reaction, anxiety behavior and formed alcoholic motivation, increases the threshold of pain response in the “hot plate” test, demonstrates anxiolytic effect.
1 cl, 2 tbl, 9 dwg, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| LOW-MOLECULAR MIMETIC BDNF AS AN AGENT FOR TREATING OPIOID DEPENDENCE | 2019 |
|
RU2707301C1 |
| DIMERIC DIPEPTIDE MIMETICS OF NEUROTROFIN-3 | 2022 |
|
RU2800369C1 |
| DIMERIC DIPEPTIDE MIMETIC BDNF AS AGENT FOR TREATING AND PREVENTING OPIOID ADDICTION | 2023 |
|
RU2823374C1 |
| AGENT FOR MANAGING ALCOHOL ABSTINENCE SYNDROME | 2012 |
|
RU2521226C2 |
| CARDIOTROPIC AGENT WITH ANXIOLYTIC AND ANALGESIC PROPERTIES | 2020 |
|
RU2773018C2 |
| MEANS FOR REDUCING ALCOHOL MOTIVATION IN ALCOHOL DEPENDENCE | 2014 |
|
RU2582966C2 |
| LINEAR SUBSTITUTED GLYPROLINE WITH ANTIDEPRESSANT AND ANALGESIC EFFECT | 2019 |
|
RU2756449C2 |
| ANXIOLYTIC AND CEREBROPROTECTIVE AGENT REDUCING INCLINATION TO ALCOHOL | 2008 |
|
RU2393855C1 |
| PHARMACEUTICAL COMPOSITION BASED ON BIS-(N-MONOSUCCINYL-L-SERYL-L-LYSINE) HEXAMETHYLENEDIAMIDE (GSB-106) | 2018 |
|
RU2697254C1 |
| 7-O-[6-O-(4-ACETYL-α-L-RHAMNOPYRANOSYL)-β-D-GLUCOPYRANOSIDO]-5-HYDROXY-6-METHOXY-2-(4-METHOXY-PHENYL)-4H-CHROMONE-4-ON, HAVING ANTI-ALCOHOL ACTION ON HIGHER NERVOUS ACTIVITY | 2014 |
|
RU2605377C2 |
